518 related articles for article (PubMed ID: 26742010)
21. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
22. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
Li Y; Liu H; Lai C; Su Z; Heng B; Gao S
Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440
[TBL] [Abstract][Full Text] [Related]
23. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
24. Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer.
Fahmy M; Mansure JJ; Brimo F; Yafi FA; Segal R; Althunayan A; Hicks J; Meeker A; Netto G; Kassouf W
Hum Pathol; 2013 Sep; 44(9):1766-72. PubMed ID: 23623586
[TBL] [Abstract][Full Text] [Related]
25. Silibinin attenuates TGF‑β1‑induced migration and invasion via EMT suppression and is associated with COX‑2 downregulation in bladder transitional cell carcinoma.
Li F; Sun Y; Jia J; Yang C; Tang X; Jin B; Wang K; Guo P; Ma Z; Chen Y; Wang X; Chang L; He D; Zeng J
Oncol Rep; 2018 Dec; 40(6):3543-3550. PubMed ID: 30272315
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells.
Zhu J; Pan X; Zhang Z; Gao J; Zhang L; Chen J
Cell Signal; 2012 Jun; 24(6):1323-32. PubMed ID: 22570869
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
[TBL] [Abstract][Full Text] [Related]
29. Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma.
Hansel DE; Platt E; Orloff M; Harwalker J; Sethu S; Hicks JL; De Marzo A; Steinle RE; Hsi ED; Theodorescu D; Ching CB; Eng C
Am J Pathol; 2010 Jun; 176(6):3062-72. PubMed ID: 20395440
[TBL] [Abstract][Full Text] [Related]
30. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
[TBL] [Abstract][Full Text] [Related]
31. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
[TBL] [Abstract][Full Text] [Related]
32. Targeting the overexpressed ROC1 induces G2 cell cycle arrest and apoptosis in esophageal cancer cells.
Zhang J; Li S; Shang Z; Lin S; Gao P; Zhang Y; Hou S; Mo S; Cao W; Dong Z; Hu T; Chen P
Oncotarget; 2017 Apr; 8(17):29125-29137. PubMed ID: 28418860
[TBL] [Abstract][Full Text] [Related]
33. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.
Tan M; Zhang D; Zhang E; Xu D; Liu Z; Qiu J; Fan Y; Shen B
Mol Carcinog; 2017 Oct; 56(10):2332-2341. PubMed ID: 28574613
[TBL] [Abstract][Full Text] [Related]
34. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
Wu CL; Ho JY; Chou SC; Yu DS
Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
[TBL] [Abstract][Full Text] [Related]
35. SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma.
Chan TC; Wu WJ; Li WM; Shiao MS; Shiue YL; Li CF
Theranostics; 2020; 10(25):11775-11793. PubMed ID: 33052246
[TBL] [Abstract][Full Text] [Related]
36. High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer.
Wang G; Huang Y; Yang F; Tian X; Wang K; Liu L; Fan Y; Li X; Li L; Shi B; Hao Y; Xia C; Nie Q; Xin Y; Shi Z; Ma L; Xu D; Liu C
Aging (Albany NY); 2020 Feb; 12(3):2030-2048. PubMed ID: 32007952
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling.
Iskender B; Izgi K; Hizar E; Jauch J; Arslanhan A; Yuksek EH; Canatan H
Tumour Biol; 2016 Jun; 37(6):8281-91. PubMed ID: 26718217
[TBL] [Abstract][Full Text] [Related]
38. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
39. TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12.
Fan Y; Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y
Clin Cancer Res; 2014 Mar; 20(6):1531-41. PubMed ID: 24449823
[TBL] [Abstract][Full Text] [Related]
40. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]